Value-Based Reimbursement in the United States, 2018 – Increasing Costs Drive Shift to Value – ResearchAndMarkets.com
The US healthcare environment has been witnessing a slow albeit continuous shift from volume- to value-based reimbursement over the past couple of decades, with the healthcare reform under the Accountable Care Act providing significant momentum for the change. While the shift has mostly affected provider reimbursement, and affected specific pockets of activity more than others, medicines reimbursement has remained mostly insulated from this dynamic.
Major VBR initiatives utilized so far include bundled payment programs, accountable care organizations (ACOs), and the oncology care model. The ACOs established under the Accountable Care Act have been growing and taking on more risk, but payers highlight integrated delivery networks (IDNs), or similar arrangements where the providers take on the risk for the outcomes as well as total c.of an entire patient population across their healthcare needs, as the most impactful approach.
Key Topics Covered
1. OVERVIEW
2. INCREASING COSTS DRIVE SHIFT TO VALUE
- US healthcare costs are rising overall
- Increasing healthcare costs impact patients' health and wealth
- Despite high healthcare spend, the US lags in health outcomes
- A response: the shift towards value-based medicine
- Bibliography
3. VALUE-BASED REIMBURSEMENT MODELS
- ACA and MACRA are key to legal frameworks in the move to value-based care
- Value-based reimbursement in Medicare and Medicaid
- Value-based reimbursement in the commercial segment
- Bibliography
4. MEETING THE CHALLENGES OF THE SHIFT TO VALUE-BASED CARE
- Several challenges remain in the shift to value-based care
- Volume-based payment systems are entrenched, and a shift to VBR could result in revenue gaps
- Shift to VBR requires a move from silo care to network-based care
- The challenge of tracking: outcomes, payments, and savings
- Physician accountability and engagement are key to a successful transition to value-based care
- Measuring value
- Who will drive the shift to VBR?
- Bibliography
5. THE PHARMA AND MEDTECH RESPONSE TO VALUE-BASED CARE
- Pharma and medtech need to proactively engage in VBR
- Building in and demonstrating value in evidence development
- Bibliography
6. OUTCOMES-BASED CONTRACTS
- Outcome-based risk-sharing deals are the mainstay of pharma's foray into VBR so far
- Barriers to use of outcome-based risk sharing
- Successful outcomes-based contracting considerations
- Bibliography
LIST OF FIGURES
Figure 1: Total national health expenditure, 1990-2025 (estimated)
Figure 2: Express Scripts' forecast for cost trends in 2017-19
Figure 3: Total national health and out-of-pocket health expenditure, 1990-2025 (estimated)
Figure 4: Alternative reimbursement models have differing levels of financial risk for the providers
Figure 5: Total national preferred formulary value (Express Scripts)
Figure 6: Likelihood of healthcare plans using value frameworks a year from the Avalere survey
Figure 7: Benefits of outcome-based contracts for payers and pharma manufacturers
Figure 8: Barriers to OBCs
Figure 9: Action needed to remove regulatory and legal barriers to outcome-based reimbursement for medical products
LIST OF TABLES
Table 1: Express Scripts top 15 therapeutic classes' drug expenditure trends in the commercial segment, 2016
Table 2: CMS VBR programs
Table 3: Challenges to the transition from volume- to value-based care
Table 4: Silos within the patient care pathway
Table 5: Selected outcomes-based contracts signed with US health insurers
Table 6: Multi-pronged market access strategy employed by Spark Therapeutics for Luxturna
Table 7: Scope of safe harbor for payer communications included in the
Table 8: Success drivers for outcomes-based contracting
For more information about this report visit https://www.researchandmarkets.com/r/gvhlvg
View source version on businesswire.com: https://www.businesswire.com/news/home/20190701005443/en/
ResearchAndMarkets.com
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Related Topics: Managed Care
Source:


State delays start of change to county’s paratransit system for low income and elderly
Genworth and Oceanwide Agree to Extend Merger Agreement, Consider Strategic Alternatives for Genworth MI Canada
Advisor News
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
More Annuity NewsHealth/Employee Benefits News
- Samantha Wildow: Mercy Health warns thousands of Medical Mutual of Ohio patients may go out-of-network in 2027
- Reports Outline Managed Care Study Results from Harvard University (Inpatient-Only List Removals Shifted Procedures To The Outpatient Setting And Reduced Medicare Spending): Managed Care
- Health and Humor: Picking a Medicare insurance plan is daunting
- Obamacare is getting more expensive in Indiana
- Hays City Commission to consider bids for health insurance, sports complex improvements
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- U-Haul Holding Company to Participate in Deutsche Bank Conference
- NAIC task force to address LTC riders
- Protective names Kurt Meyers Chief Legal Officer and Fernando Levy Chief Digital & AI Officer
- Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
More Life Insurance News